Inactive Instrument

News Calmare Therapeutics Incorporated

Equities

CTTC

US13126R1023

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

CALMARE THERAPEUTICS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	09/06/20	AQ
Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract	09/06/20	CI
Calmare Therapeutics Incorporated Announces Board Changes	19/07/19	CI
Carl O'connell to Resign as Member of the Board of Directors of Calmare Therapeutics Incorporation, Effective on or About June 26, 2019	12/06/19	CI
Declaration of Voting Results by Calmare Therapeutics	02/07/18	CI
Calmare Therapeutics Declares Preliminary Tally of Consents by Shareholders	15/06/18	CI
Calmare Therapeutics Solicits Proxies from Shareholders	16/01/18	CI
Calmare Therapeutics Solicits Proxies from Shareholders	12/01/18	CI
Calmare Therapeutics Solicits Proxies from Shareholders	02/01/18	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	08/12/17	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	04/12/17	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	22/11/17	CI
Stanley Yarbro Sends Letter to Board of Directors of Calmare Therapeutics	21/09/17	CI
Stanley Yarbro Sends Director Nomination Notice to Calmare Therapeutics	21/09/17	CI
Stanley Yarbro Threatens Calmare Therapeutics with Legal Action	21/09/17	CI
Calmare Therapeutics Incorporated Auditor Raises 'Going Concern' Doubt	20/07/17	CI
Stanley Yarbro Sends Letter to Calmare Therapeutics	30/06/17	CI
Calmare Therapeutics, Inc. Removes Stan Yarbro as Director	23/03/17	CI
Calmare Therapeutics Incorporated Resignation of Robert T. Conway and Steve Roehrich from the Board	23/02/17	CI
Calmare Therapeutics Incorporated cancelled the transaction announced on September 10, 2013	09/09/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Calmare Therapeutics Incorporated

Equities

CTTC

US13126R1023

Summary

Filters